Fulltext

Transcutaneous continuous carbon dioxide tension monitoring reduced incidence, degree and duration of hypercapnia during combined regional anaesthesia and monitored anaesthesia care in shoulder surgery patients

Baulig, Werner ; Keselj, Marija ; Baulig, Barbara ; Guzzella, Sandra ; Borgeat, Alain ; Aguirre, José

In: Journal of Clinical Monitoring and Computing, 2015, vol. 29, no. 4, p. 499-507

Ajouter à la liste personnelle
    Titre
    • Transcutaneous continuous carbon dioxide tension monitoring reduced incidence, degree and duration of hypercapnia during combined regional anaesthesia and monitored anaesthesia care in shoulder surgery patients
    Auteur
    • Baulig, Werner. Department of Anaesthesiology and Intensive Care Medicine, Klinik Im Park, Seestrasse 220, 8027, Zurich, Switzerland
    • Keselj, Marija. Institute of Anaesthesiology, University Hospital Zurich, Zurich, Switzerland
    • Baulig, Barbara. Institute of Anaesthesiology, University Hospital Zurich, Zurich, Switzerland
    • Guzzella, Sandra. Institute of Anaesthesiology, University Hospital Zurich, Zurich, Switzerland
    • Borgeat, Alain. Institute of Anaesthesiology, University Hospital Zurich, Zurich, Switzerland
    • Aguirre, José. Institute of Anaesthesiology, University Hospital Zurich, Zurich, Switzerland
    Type de document
    • Postprint
    Langue
    • Anglais
    Publié dans
    • Journal of Clinical Monitoring and Computing, 2015, vol. 29, no. 4, p. 499-507. Springer Netherlands
    Autre version électronique
    Identifiant OAI-PMH
    • oai:doc.rero.ch:332795
    Summary
    We studied the impact of transcutaneous continuous carbon dioxide tension (PtcCO2) monitoring on ventilation and oxygenation during monitored anaesthesia care (MAC) in patients scheduled for shoulder surgery with continuous interscalene block. 50 patients were randomised either to the intervention (I-group) or the control (C-group) group. In both groups MAC was performed using target controlled infusion of propofol and remifentanil. MAC regimen was adapted to PtcCO2 values in the I-group, whereas the C-group was blinded for these values. Primary outcome was the incidence, degree and duration of hypoventilation stages. In the I-group and the C-group the mean±SD [range] of PtcCO2 and PaCO2 was 5.79±0.84 [4.37] and 5.44±0.59 [2.78] kPa, as well as 6.41±1.17 [6.29] and 6.01±0.96 [7.15] kPa. Periods of PtcCO2/PaCO2>6.5kPa were 21.0±35.7/1.2±4.2min in the I-group and 45.6±40.0/18.6±26.8min in the C-group. Severe hypercapnia (PtcCO2 and/or PaCO2>7.5kPa) was dected in 3/0 patients of the I-group and in 10/3 patients of the C-group. PtcCO2 and PaCO2 showed a strong correlation (r=0.78), but only moderate agreement with a mean bias (LOA) of −0.37 (−1.69; +0.95) kPa showing an overestimation of the PaCO2. Sensitivity and specificity of PtcCO2 to detect changes of PaCO2 was 0.94 and 0.56, respectively. In no patient SpO2 or SaO2 values lower than 90% were measured. Despite a moderate agreement between PaCO2 and PtcCO2 the PtcCO2 monitoring significantly reduced incidence, degree and duration of hypercapnia in shoulder surgery patients with MAC.